These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11858878)

  • 21. Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys.
    Egan AF; Blackman MJ; Kaslow DC
    Infect Immun; 2000 Mar; 68(3):1418-27. PubMed ID: 10678955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1.
    Burns JM; Flaherty PR; Romero MM; Weidanz WP
    Vaccine; 2003 May; 21(17-18):1843-52. PubMed ID: 12706668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection.
    Elias SC; Collins KA; Halstead FD; Choudhary P; Bliss CM; Ewer KJ; Sheehy SH; Duncan CJ; Biswas S; Hill AV; Draper SJ
    J Immunol; 2013 Feb; 190(3):1135-47. PubMed ID: 23293353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.
    Kumar S; Yadava A; Keister DB; Tian JH; Ohl M; Perdue-Greenfield KA; Miller LH; Kaslow DC
    Mol Med; 1995 Mar; 1(3):325-32. PubMed ID: 8529111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane antigen 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1.
    Faber BW; Remarque EJ; Morgan WD; Kocken CH; Holder AA; Thomas AW
    Infect Immun; 2007 Dec; 75(12):5947-55. PubMed ID: 17938224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization of Aotus monkeys with recombinant cysteine-rich interdomain region 1 alpha protects against severe disease during Plasmodium falciparum reinfection.
    Makobongo MO; Keegan B; Long CA; Miller LH
    J Infect Dis; 2006 Mar; 193(5):731-40. PubMed ID: 16453270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A.
    Walsh DS; Gettayacamin M; Leitner WW; Lyon JA; Stewart VA; Marit G; Pichyangkul S; Gosi P; Tongtawe P; Kester KE; Holland CA; Kolodny N; Cohen J; Voss G; Ballou WR; Heppner DG
    Vaccine; 2006 May; 24(19):4167-78. PubMed ID: 16574282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of biologically active antibodies in mice, rabbits, and monkeys by Plasmodium falciparum EBA-175 region II DNA vaccine.
    Sim BK; Narum DL; Liang H; Fuhrmann SR; Obaldia N; Gramzinski R; Aguiar J; Haynes JD; Moch JK; Hoffman SL
    Mol Med; 2001 Apr; 7(4):247-54. PubMed ID: 11471569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion.
    Kocken CH; Withers-Martinez C; Dubbeld MA; van der Wel A; Hackett F; Valderrama A; Blackman MJ; Thomas AW
    Infect Immun; 2002 Aug; 70(8):4471-6. PubMed ID: 12117958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice.
    Narum DL; Kumar S; Rogers WO; Fuhrmann SR; Liang H; Oakley M; Taye A; Sim BK; Hoffman SL
    Infect Immun; 2001 Dec; 69(12):7250-3. PubMed ID: 11705894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1.
    Goodman AL; Epp C; Moss D; Holder AA; Wilson JM; Gao GP; Long CA; Remarque EJ; Thomas AW; Ammendola V; Colloca S; Dicks MD; Biswas S; Seibel D; van Duivenvoorde LM; Gilbert SC; Hill AV; Draper SJ
    Infect Immun; 2010 Nov; 78(11):4601-12. PubMed ID: 20713623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
    Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L
    Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anemia in parasite- and recombinant protein-immunized aotus monkeys infected with Plasmodium falciparum.
    Jones TR; Stroncek DF; Gozalo AS; Obaldia N; Andersen EM; Lucas C; Narum DL; Magill AJ; Sim BK; Hoffman SL
    Am J Trop Med Hyg; 2002 Jun; 66(6):672-9. PubMed ID: 12224573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
    Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine.
    Longley RJ; Halbroth BR; Salman AM; Ewer KJ; Hodgson SH; Janse CJ; Khan SM; Hill AVS; Spencer AJ
    Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28031267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of HLA-DRB1 alleles on antibody responses to PfCP-2.9-immunized and naturally infected individuals.
    Zhang Q; Xue X; Xu X; Wang C; Chang W; Pan W
    J Clin Immunol; 2009 Jul; 29(4):454-60. PubMed ID: 19247821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization.
    Jiang G; Charoenvit Y; Moreno A; Baraceros MF; Banania G; Richie N; Abot S; Ganeshan H; Fallarme V; Patterson NB; Geall A; Weiss WR; Strobert E; Caro-Aquilar I; Lanar DE; Saul A; Martin LB; Gowda K; Morrissette CR; Kaslow DC; Carucci DJ; Galinski MR; Doolan DL
    Malar J; 2007 Oct; 6():135. PubMed ID: 17925026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara.
    Thera MA; Coulibaly D; Kone AK; Guindo AB; Traore K; Sall AH; Diarra I; Daou M; Traore IM; Tolo Y; Sissoko M; Niangaly A; Arama C; Baby M; Kouriba B; Sissoko MS; Sagara I; Toure OB; Dolo A; Diallo DA; Remarque E; Chilengi R; Noor R; Sesay S; Thomas A; Kocken CH; Faber BW; Imoukhuede EB; Leroy O; Doumbo OK
    Malar J; 2016 Aug; 15(1):442. PubMed ID: 27577237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids.
    Wang R; Doolan DL; Charoenvit Y; Hedstrom RC; Gardner MJ; Hobart P; Tine J; Sedegah M; Fallarme V; Sacci JB; Kaur M; Klinman DM; Hoffman SL; Weiss WR
    Infect Immun; 1998 Sep; 66(9):4193-202. PubMed ID: 9712767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenovectors induce functional antibodies capable of potent inhibition of blood stage malaria parasite growth.
    Bruder JT; Stefaniak ME; Patterson NB; Chen P; Konovalova S; Limbach K; Campo JJ; Ettyreddy D; Li S; Dubovsky F; Richie TL; King CR; Long CA; Doolan DL
    Vaccine; 2010 Apr; 28(18):3201-10. PubMed ID: 20188680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.